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View OnlineLuminescent quantum clusters of gold in transferrin family protein, lactoferrin
exhibiting FRET†
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and Thalappil Pradeep*a
Received 4th June 2010, Accepted 23rd July 2010
DOI: 10.1039/c0nr00377hWe report the synthesis of highly luminescent, water soluble quantum clusters (QCs) of gold, which are
stabilized by an iron binding transferrin family protein, lactoferrin (Lf). The synthesized AuQC@Lf
clusters were characterized using UV-Visible spectroscopy, X-ray photoelectron spectroscopy (XPS),
transmission electron microscopy (TEM), photoluminescence (PL), matrix assisted laser desorption
ionization mass spectrometry (MALDI-MS), FTIR spectroscopy and circular dichroism (CD)
spectroscopy along with picosecond-resolved lifetime measurements. Detailed investigations with
FTIR and CD spectroscopy have revealed changes in the secondary structure of the protein in the
cluster. We have also studied F€orster resonance energy transfer (FRET) occurring between the protein
and the cluster. The ability of the clusters to sense cupric ions selectively at ppm concentrations was
tested. The stability of clusters in widely varying pH conditions and their continued luminescence make
it feasible for them to be used for intracellular imaging and molecular delivery, particularly in view of Lf
protection.1. Introduction
The ardent quest for materials with novel properties has driven
us to synthesize nanomaterials such as quantum dots (QDs),
nanorods, etc.1,2 Applications and safety of these materials have
become important aspects of science and engineering in the
recent past. Luminescent nanomaterials like QDs are potential
candidates for biological and optoelectronic applications but
their proven cytotoxicity in the unprotected form3–5 urges us to
look for novel and biocompatible materials. Noble metal
quantum clusters (NMQCs) are one such class of materials which
have been of recent interest in our group.6–9 NMQCs exhibit
highly polarizable transitions which scale in size with EFermi/N
1/3
where EFermi is Fermi energy of the bulk metal and N is the
number of atoms. Luminescence in them arises from intraband
transitions, and these conduction-electron transitions are the
low-number limit of the plasmons—the collective dipole oscil-
lations occurring when a continuous density of states is
reached.10 Quantum clusters of gold are distinctly different from
bulk and metallic nanoparticles, containing very few atoms. They
have a sub-nanometre core size with discrete energy levels andaDST Unit on Nanoscience (DST UNS), Department of Chemistry and
Sophisticated Analytical Instrument Facility, Indian Institute of
Technology Madras, Chennai, 600 036, India. E-mail: pradeep@iitm.ac.in
bDepartment of Biotechnology, Indian Institute of Technology Madras,
Chennai, 600 036, India
cUnit for Nanoscience and Technology, Department of Chemical,
Biological and Macromolecular Sciences, Satyendra Nath Bose National
Centre for Basic Sciences, Block JD, Sector III, Salt Lake, Kolkata, 700
098, India
† Electronic supplementary information (ESI) available: Additional
information concerning SDS-PAGE analysis of NLf, solid state
luminescence, PL spectra of AuQC@ALf, AuQC@NLf and AuQC@HLf
and comparison at different temperatures, TEM images, EDAX,
UV-Visible spectra. See DOI: 10.1039/c0nr00377h
This journal is ª The Royal Society of Chemistry 2010show molecule-like properties in their absorption and photo-
luminescence features. Such clusters of gold and silver are
synthesized by various methods with suitable ligands containing
thiol and amine groups11–14 such as short peptides (e.g. gluta-
thione)6,11 and proteins7,15,16 (e.g. bovine serum albumin (BSA)).
Applications of proteins and peptides to synthesize inorganic
nanomaterials was discussed in detail by Dickerson and co-
workers.17 Protein protected luminescent NMQCs are attractive
due to simplicity in their preparation and potential applications.
In this context, the reducing ability of tyrosine and other
aromatic amino acids under basic pH (>11) was exploited
followed by stabilization of the core by the cysteine residues of
the protein.15
Lactoferrin (Lf) is a multifunctional protein of the transferrin
family, which are iron-binding glycoproteins. Lf has a molecular
weight of 83 kDa and it is cationic with an isoelectric point of
8.5–9.0. It is found in biological fluids such as milk, blood, cervical
mucus, seminal fluids, saliva, tears, and within the specific gran-
ules of polymorphonuclear leukocytes. It can be found in three
different forms depending on the percentage of iron content,
Native lactoferrin (NLf, Fe3+ < 20%), hololactoferrin (HLf, iron
saturated) and apolactoferrin (ALf, iron depleted form). It
exhibits antimicrobial, antiviral, immunomodulation, anti-
oxidation anti-inflammation, antistress, and analgesic effects, as
well as causes enhancement in lipid metabolism. It is one of the few
proteins which can cross the blood–brain barrier. Extensive
studies have been done in the recent past on the properties,
mammalian receptors and applications of Lf.18–23,30 Lf has
receptors on several Gram negative bacteria too.24 The in vivo
clinical applications of transferrin family proteins are well
known.25 Lactoferrin has been used to functionalize iron oxide
nanoparticles.26 Recently it has been used in receptor mediated
drug delivery, cancer therapy and gene delivery targeting brain as
well as for oral drug delivery.27–30 Multifunctional thin films ofNanoscale, 2010, 2, 2769–2776 | 2769
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View Onlinelactoferrin have also been produced.31 The EMEA (European
Medicines Agency) and FDA (Food and Drug Administration)
have granted permission to use it as orphan drug in treating
cystic fibrosis.32,33
Owing to the composition of lactoferrin (34 cysteine residues
and 22 tyrosine residues),18 we thought this protein could be
a candidate to make biocompatible and functionalized quantum
clusters of gold and can be used for some interesting applications.
To the best of our knowledge this is the first time lactoferrin was
used as both reducing and stabilizing agent for the production
and stabilization of gold nanoparticles as well as quantum clus-
ters. In the recent past, studies done in our group have shown
that quantum clusters reduced and stabilized with BSA are
nontoxic and can be used for targeted cancer cell imaging.6,7
Hence there is possibility that these lactoferrin stabilized clusters
can also be used for similar applications.
2. Experimental
2.1 Reagents, materials and instruments
Tetrachloroauric acid trihydrate (HAuCl4$3H2O) was purchased
from CDH, India. Native bovine lactoferrin, 17.5% iron
saturated, purity >96% of Taradon Laboratory was a kind gift
from the company Tablets India Pvt Ltd, Chennai, India. The
purity of the protein was tested by SDS–PAGE and MALDI–
TOF MS and no impurities were detected (Fig. S1 of the ESI†).
Millipore water was used throughout the experiments. Sodium
hydroxide pellets from Qualigens Pvt Ltd and Citric Acid from
Merk Pvt Ltd were used for the experiments. Potassium bromide
(spectroscopic grade) used for infrared studies, was purchased
from Merck. Sinapinic acid was used as the matrix for MALDI-
TOF MS. All chemicals were used as such without further
purification.
2.2 Instrumentation
UV/Vis spectra were measured with a Perkin Elmer Lambda 25
instrument in the range 200–1100 nm. Luminescence measure-
ments were carried out on a Jobin Vyon NanoLog instrument.
The band pass for excitation and emission was set as 2 nm.
Luminescence transients were measured and fitted by using
a commercially available spectrophotometer (LifeSpec-ps) from
Edinburgh Instruments, UK (80 ps instrument response function
(IRF)). The clusters were excited at 445 nm and the emission
decays were collected at 650 nm. For the FRET study, we have
used a femtosecond-coupled TCSPC (time-correlated single-
photon counting) set-up. The sample was excited at 300 nm using
the third harmonic of a mode-locked Ti-sapphire laser (Tsunami,
Spectra-Physics) pumped by 10 W Millennia (Spectra Physics).
The high repetition 80 MHz of the Ti:sapphire laser was lowered
to 8 MHz using a pulse picker (Spectra-Physics, model 3980) to
accommodate the timing capability of the electronics system. The
fundamental output wavelength of the laser was tuned to 900 nm
and frequency doubled to 450 nm. The second harmonic was
monitored by a THORLABS DET10A/M Si based photodiode.
This photodiode signal was then sent to a HORIBA JOBIN
YVON TB-01 triggering electronics to generate the start pulse.
Finally, all of the fluorescence transients were measured at magic
angle. X-ray photoelectron spectroscopy (XPS) measurements2770 | Nanoscale, 2010, 2, 2769–2776were conducted using an Omicron ESCA Probe spectrometer
with polychromatic Mg Ka X-rays (hy ¼ 1253.6 eV). The
samples were spotted as drop-cast films on a sample stub. A
constant analyzer energy of 20 eV was used for the measure-
ments. High resolution transmission electron microscopy of
clusters was carried out with a JEOL 3010 instrument. The
samples were drop casted on carbon-coated copper grids and
allowed to dry under ambient conditions. Matrix-assisted laser-
desorption ionization mass spectrometry (MALDI-MS) studies
were conducted using a Voyager-DE PRO Biospectrometry
Workstation from Applied Biosystems. A pulsed nitrogen laser
of 337 nm was used for the MALDI-MS studies. Mass spectra
were collected in positive-ion mode and were averaged for 100
shots. FTIR spectra were measured with a Perkin Elmer Spec-
trum One instrument. KBr crystals were used as the matrix for
preparing samples. The second derivative of FTIR spectrum was
taken using ‘‘spectrum one’’ software provided by Perkin Elmer.
Far-UV CD spectrum was obtained using a J-600 Spec-
tropolarimeter (JASCO).2.3 The PL quantum yield measurements AuQC@Lf
The PL quantum yields of AuQC@Lf samples were determined
by the integrated luminescence intensity method by comparison
of the luminescence emission with the standard reference sample
of fluorescein in 0.1M NaOH at 27 C. The luminescence emis-
sion of a sample can be written in a formula with related
parameters.
F ¼ KFCslI
Where F is the photoluminescence quantum yield of the sample,
C is the number density of fluorophores (concentration of the
sample), s is the one-photon absorption cross section, l is the
path length in which photons are absorbed, I is the flux of inci-
dent photons (photons cm2 s), F is the integrated luminescence
signal in the emission region, and K is an instrument parameter.
Here, all luminescence signals were measured under SPE (single
photon excitation) of 494 nm with the same experimental
conditions, in the same system, so that K, l, and I are the same for
AuQC samples and reference samples. Using the above formula
for AuQC and fluorescein, the PL quantum yield, Fs of AuQC can
then be determined by comparison with the known, Fr of fluo-
rescein as follows:
Fs ¼ Fs
Csss
 Crsr
Fr
 Fr
where the terms with suffixes r and s mean reference fluorescein
and AuQC, respectively. Since the product, Cs represents the
absorption of the sample, the term of Crsr/Cssscan be replaced
by Ar/As where A is the absorption coefficient of the sample at the
excitation wavelength. When the values of Ar and As are
measured, Fs of AuQC can be obtained from,
Fs ¼ Fs
As
 Ar
Fr
 Fr
We measured Ar and As at 494 nm in a UV-visible spectrometer
and for both, the absorption coefficients were set as 0.1. Then the
photoluminescence intensities of these samples were measured.This journal is ª The Royal Society of Chemistry 2010
Fig. 1 (A) UV-visible spectra of the evolution of clusters. Concentration
of NLf was kept constant (150 mM) and the molar ratio of NLf : gold was
varied. The spectra were collected after 24 h of the reaction; 1 : 3 (black),
1 : 8(red), 1 : 17 (green), 1 : 33 (blue), 1 : 67 (cyan) and 1 : 83 (magenta).
Clusters were formed only at certain gold : Lf ratios. Schematic of the
cluster in protein is shown in the inset. (B) Photograph showing the
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View Online2.4 Energy transfer efficiency measurement
The steady-state transfer efficiency, E is measured using the
relative fluorescence intensity of the donor, in the absence (FD)
and presence (FDA) of the acceptor as,
E ¼ 1 FDA
FD
For donor–acceptor (D–A) systems decaying with multi-
exponential lifetimes, the time-resolved energy transfer efficiency
(E) is calculated from the amplitude weighted lifetimes
hsi ¼P
i
aisi of the donor in absence (sD) and presence (sDA) of
the acceptor as,
E ¼ 1  sDA
sD
2.5 Synthesis
AuQC@NLf was prepared as follows. It follows the procedure in
Scheme 1. Briefly, tetrachloroauric acid trihydrate
(HAuCl4$3H2O) and NLf were mixed and stirred using
a magnetic stirrer for 2 min. To this, 1 M NaOH was added, its
final concentration in the mixture was 5%. This reaction mixture
was stirred for 24 h, which yields highly luminescent quantum
clusters when the Au : NLf ratio was of 17 : 1, by molarity. ALf
and HLf were prepared by the method given by Roland et al.34
ALf was prepared by dialyzing NLf against 0.1 M citric acid at pH
2.3. Extensive dialysis against distilled water was done to remove
excess citric acid and Fe3+ ions. HLf was prepared by dialyzing
NLf against excess Fe3+ ions in the presence of CO3
2 ions. Excess
Fe3+ ions were removed by dialysis against deionized water. The
iron saturation level was monitored by UV-visible spectroscopy.
AuQC@ALf and AuQC@HLf were prepared by the same method
as mentioned above for AuQC@NLf. QCs were formed only in the
concentration range of 2.5 mM to 10 mM of Au3+ for 150 mM of
lactoferrin (molar ratio 8 : 1 to 33 : 1) and these clusters protected
with NLf are referred to as AuQC@NLf. Nanoparticles formed at
higher concentration of Au3+ are referred to as AuNP@NLf.
emission of clusters and nanoparticles formed at various metal ion
concentrations, keeping the NLf concentration the same at 150 mM. In
visible light (above) and in UV light (below).3. Results and discussion
3.1 UV-Visible spectroscopic studies
The clusters were formed only in specific window of concentra-
tions. The absorption spectra of clusters formed at various
Au : NLf ratios are presented in Fig. 1A. At higher concentra-
tions of HAuCl4 : NLf (83 : 1, 67 : 1 molar ratios), surface
plasmon resonance of non-luminescent gold nanoparticles,
absorbtion at 530 nm can be seen. Cluster formation begins at
the HAuCl4 : NLf ratio of 33 : 1, hence the product obtained atScheme 1 Synthetic procedure to make AuQC@NLf.
This journal is ª The Royal Society of Chemistry 2010this concentration was a mixture of luminescent clusters and
nanoparticles. As we reduced the concentration of HAuCl4 : NLf
(17 : 1, 8 : 1), the plasmonic peak intensity gradually reduced and
disappeared, but the features of aromatic amino acids in protein
retained at 280 nm. The clusters do not show any distinct
absorption features, as in the case of bovine serum albumin
(BSA) protected quantum clusters.7,15 At this optimized
concentration of HAuCl4 : NLf of 17 : 1, the resulting product
was luminescent with red emission. However, further reduction
in the concentration HAuCl4 : NLf to 3 : 1 did not yield lumi-
nescent clusters. When the experiment was done in the absence of
NaOH, only nanoparticles were formed. The clusters were seen
after 8 h of incubation itself. However, after 24 h of incubation,
no change was seen in the spectrum. Intense luminescence from
the clusters was observable to the naked eye. As a result, the
emission could be photographed (Fig. 1B). As can be seen, as
a function of Au concentration, different shades of red are
observed. However, as the concentration is increased beyond theNanoscale, 2010, 2, 2769–2776 | 2771
D
ow
nl
oa
de
d 
on
 2
7 
Ju
ly
 2
01
1
Pu
bl
ish
ed
 o
n 
30
 S
ep
te
m
be
r 2
01
0 
on
 h
ttp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
NR
003
77H
View Onlinecritical value, nanoparticles are seen, which do not exhibit any
observable emission. These clusters were luminescent in solid
state also (Fig. S2 of the ESI†). At low temperature enhancement
in luminescence intensity was observed (Fig. S3 of the ESI†).
Quantum clusters of gold were also formed by ALf and by HLf
(Fig. S3 of the ESI†), irrespective of its iron content and no
obvious change in the position of emission was observed. Thus
Fe3+ bound to the protein does not interfere in cluster formation.
The concentration at which clusters are formed is also not
affected significantly in all the three proteins, NLf, ALf and HLf.Table 1 Excited state lifetime of the tryptophans in NLf and
AuQC@NLf. The number in parenthesis indicated the relative contribu-
tion of the time components
Tryptophan
emission (350 nm) s1/ns s2/ns s3/ns <s>/ns
NLf 0.11 (49%) 1.17 (37%) 4.11 (14%) 1.06
AuQC@NLf 0.05 (71%) 0.84 (16%) 3.38 (13%) 0.603.2 Fluorescence time resolved studies
Inset of Fig. 2A shows the emission spectra of the as-synthesized
clusters. In all cases, luminescent features showed a broad
emission maximum at650 nm, which had two features centered
at 643 and 658 nm. Multiple peak maxima in the emission are
attributed to multiple cluster size distributions or the presence of
different chemical environments of the metal core. The emission
spectra of NLf are shown in the inset of Fig. 2B. It is clear from
Fig. 1A and inset of Fig. 2B that there is a significant spectral
overlap between the NLf emission and the absorption of the
cluster (AuQC@NLf). From Fig. 2D we observed that when the
cluster is excited at 380 nm, it shows two peaks, one at 450 nm,
due to the weak luminescence of the protein, which was observed
upon excitation of protein alone at 380 nm, thus confirming that
it is from the protein,35 and another at 650 nm due to the clusterFig. 2 (A) Fluorescence decay profile of AuQC@NLf cluster at 650 nm (excita
and AuQC@HLf (solid line), excited at 445 nm. (B) Picosecond-resolved fluo
350 nm (excitation at 300 nm). Steady-state PL quenching of the tryptophan e
is shown in the inset. (C) Schematic of the occurrence of FRET between Lf and
to right) taken in visible light (above) and in UV light (below). (D) Photolu
wavelength 380 nm); the excitation spectra collected correspond to 650 nm em
is due to the weak luminescence of the protein when excited at 380 nm.
2772 | Nanoscale, 2010, 2, 2769–2776core. This spectral overlap is expected to reveal the proximity of
the cluster to the tryptophan residues of the protein NLf through
energy transfer from tryptophan (donor) to Au cluster
(acceptor). As revealed from the inset of Fig. 2B, the overall
steady state emission intensity of the donor emission (NLf)
drastically decreased in the presence of the acceptor
(AuQC@NLf). Also, the faster decay of the donor (NLf) in the
presence of acceptor (AuQC@NLf) (Fig. 2B) as compared to the
free donor confirms F€orster resonance energy transfer from
tryptophan residues of NLf to the Au cluster of AuQC@NLf
(Table 1). FRET in AuQC conjugated to fluorophore has been
reported by our group earlier.36 The calculated donor-to-
acceptor energy transfer efficiency from steady-state and time-
resolved studies are found to be 80 and 43%, respectively. For
a well-behaved system, the ratio of the integrated areas under the
time-resolved emission decays for donor and donor–acceptor
complexes should correlate with the integrated areas under thetion at 445 nm). Inset shows emission spectra of AuQC@NLf (broken line)
rescence transients of donor (NLf) and donor–acceptor (AuQC@NLf) at
mission (donor; NLf) in the presence of acceptor Au cluster (AuQC@NLf)
cluster. Inset shows the photographs of (i) NLf (ii) AuQC@NLf (from left
minescence spectra AuQC@NLf show emission at 650 nm (excitation
ission, which shows peaks at 380 nm and 510 nm. The emission at 450 nm
This journal is ª The Royal Society of Chemistry 2010
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View Onlinesteady-state emission spectra. In principle, one of the methods,
namely steady-state or time-resolved, can be used to estimate
energy transfer efficiency. However, there could be a disagree-
ment between the estimated energy transfer efficiency from these
two methods as explained below. FRET is a nonradiative process
whereby an excited state donor (D) transfers energy to a prox-
imal ground state acceptor (A) through long-range dipole–dipole
interactions. The rate of energy transfer is highly dependent on
many factors, such as the extent of spectral overlap, the relative
orientation of the transition dipoles, and, most importantly, the
distance between the donor and acceptor molecules. In the
steady-state, there is also a possibility of quenching due to re-
absorption of the donor emission by the acceptor through the
radiative mechanism of energy transfer, which is not a dipole
oriented process. In case of time-resolved measurement, this
radiative energy transfer does not contribute to the overall life-
time of the fluorophore. Therefore, the energy transfer is over-
estimated in the steady-state and includes the re-absorption,
thereby giving a higher efficiency value. In one of our recent
studies, we have reported the potential danger of using steady-
state fluorescence quenching to conclude the nature of energy
transfer as F€orster type and to estimate energy transfer effi-
ciency.37 As the dimensions of the Lf protein, measured by X-ray
diffraction, are 13.89  8.7  7.34 nm,38 the distance between the
donor tryptophan residues and the cluster protected by the
protein is likely to be less than 10 nm, which is essential for
FRET to occur. To the best of our knowledge, this is the first
time we report the FRET process occurring between the protein
and AuQC inside the protein. It is to be noted that the measured
quantum yield gives values of 6.0%, 5.9%, 1.23% for
AuQC@NLf, AuQC@apoLf, AuQC@HLf (100% Fe
3+ saturated),
respectively. This enhancement of quantum yield of clusters
synthesized in protein molecules is still under investigation and
will be presented in a subsequent report.
Time-resolved decay of AuQC@NLf was measured at 650 nm.
Data were collected using a picosecond-resolved time correlated
single photon counting (TCSPC) technique (Fig. 2A). Lifetime
values were obtained by the multi-exponential fitting of the
luminescence at 650 nm (an excitation wavelength of 445 nm was
used to avoid exciting tryptophan). Time components are 0.18 ns
(58%), 0.82 ns (22%), 3.58 ns (11%) and 110.70 ns (9%). The
uplift of the decay with respect to the IRF (instrument response
function) is due to the presence of a long time component of
111 ns (9%) which is not complete within the experimental time
window of 50 ns. A fast time scale major component is seen in
a number of QCs of gold. Examples include, Au25, Au22 and
Au23.
6 In general, these clusters exhibit a large component of
a few tens of picoseconds and several slow components of na-
noseconds. A similar situation is seen in the case of AuQC@BSA.
7Fig. 3 MALDI mass spectra of NLf and AuQC@NLf. Spectrum of NLf
was measured at pH 12. There are two cluster features.3.3 TEM and MALDI-TOF-MS studies
TEM images have shown the presence of sub-nanometre sized
clusters in AuQC@NLf (Fig. S4 of the ESI†) which are compared
with the TEM image of AuNP@NLf, formed at higher gold
concentrations. The clusters are shown with white circles. At
lower gold concentration, a larger fraction of smaller clusters is
seen, in agreement with the optical absorption spectrum. These
clusters are sensitive to high energy electron beams andThis journal is ª The Royal Society of Chemistry 2010nanoparticles were formed due to continuous electron beam
irradiation due to aggregation of the clusters (Fig. S5 of the
ESI†). Therefore, the image (Fig. S4 of the ESI†) was taken
immediately after exposure. The cluster core dimension could
not be established accurately from the current images, but it is
below 1 nm. EDAX of the sample was taken, which shows the
presence of Au, S and Fe (Fig. S6 of the ESI†).
Mass spectra of the protein and the cluster were measured by
MALDI-TOF-MS (Fig. 3). Sinapinic acid mixed with urea was
used as the matrix for the samples. The detailed method of
sample preparation is explained in supplementary information
7.† The spectra were collected in the positive mode. The mass
spectrum of NLf shows two distinct peaks at 41.5 and 83.0 kDa
due to the di- and mono- cations. These peaks are in agreement
with the previously reported values.39,40 The protein and the
cluster samples did not show features beyond 100 kDa. The
major peak observed for NLf was at m/z 83 024. AuQC@NLf
showed two distinct, but low intensity peaks at m/z 85 570 and
87 965 besides the parent protein peak. The difference between
the peak at m/z 87 965 and the parent protein corresponds to
Au25 and we tentatively assign the peak to an Au25 core encap-
sulated in the protein, However, smaller clusters are also
expected to be in the protein, as shown by the peak at m/z
85 570. The cluster cores alone were not observed, as expected as
they are fragile species and are tightly bound in the protein. The
overall ion intensity was significantly reduced in the cluster
sample and the peaks were broadened. This spectral behavior is
consistent with BSA clusters.7 As the intensity was low, a post
source decay analysis could not be done to understand the nature
of the cluster. The protein structure itself appears to have
undergone significant changes as the dication intensity was poor.
The data suggest that the cluster is fully encapsulated by a single
protein molecule.3.4 XPS studies
Further analysis was done with X-ray photoelectron spectros-
copy (XPS), for the optimized concentration of gold:NLfNanoscale, 2010, 2, 2769–2776 | 2773
Fig. 4 (A) Au 4f core level photoelectron spectrum of the AuQC@NLf
cluster. (B) S 2p core level photoelectron spectrum of AuQC@NLf. The
components are fitted. Two sets of spin–orbit split components are
marked in both.
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View Online(17 : 1). All the expected elements were seen. The Au core level
showed principal Au 4f7/2 and Au 4f5/2 components at 84.2 and
87.9 eV binding energy. This confirms the formation of stable Au
clusters by reduction of HAuCl4. The core is close to Au(0),
although a minor shift to the higher binding energy, due to
reduced size is noted (Fig. 4A). The spectrum has a higher
binding energy component, although weak, which may be
attributed to the smaller clusters or surface atoms of a given
cluster. The S 2p region suggests that the monolayer of the
clusters is sensitive to the X-ray beam and as a result, two 2p3/2
features are seen at 165.8 and 168.0 eV, attributed to oxidized
states of sulfur (Fig. 4B). This is seen in thiolate protected clus-
ters upon X-ray exposure, leading to sulfite, sulfonate and sulfate
species.41 Au : S atomic ratio measured from the area of Au 4f
and S 2p features is 1 : 3.75 which implies that there is freeFig. 5 (A) Comparison of the FTIR spectra of NLf and AuQC@NLf. (B) Co
(1600–1690 cm1) of NLf and AuQC@NLf, showing bands appearing due to s
AuQC@NLf.
2774 | Nanoscale, 2010, 2, 2769–2776lactoferrin in the sample even at optimized concentration. This is
consistent with the MALDI-MS data.3.5 FTIR and CD spectroscopic studies
CD spectroscopy and FTIR spectroscopy are excellent tools to
monitor changes in the secondary structure of proteins. We have
employed both these methods to study the conformational
behavior of NLf before and after the formation of the cluster.
Fig. 5A shows a comparison between the FTIR spectra of NLf
and AuQC@NLf. The characteristic stretching and bending
vibrations arising due to amide bonds which link amino acids are
assigned as amide I (1600–1690 cm1), amide II (1480–
1575 cm1), amide III (1229–1301 cm1) and amide A
(3300 cm1).42 The band appearing at 700 cm1 can be
assigned to –NH2 and –NH wagging and that at 2960 cm1 is
due to C–H vibrations.43 Other bands are those at 1400 cm1
(C]O stretching of COO), 1468 cm1 (C–H deformation of
>CH2), and 3500 cm1 (O–H stretching).44 As Lf is a glyco-
protein, the broad structure from 900–1200 cm1 is due to C–O,
C–C stretches and C–O–H, C–O–C deformation of carbohy-
drates.44 In general, the cluster spectrum is broader than the
protein and several features are merged. As the amide I band is
most sensitive to protein secondary structures, we have studied
the second derivative of FTIR spectra of NLf and AuQC@NLf in
the 1600–1690 cm1 range (Fig. 5B). Generally the band
assignments in the amide I region for protein secondary struc-
tures are as follows. The bands between 1648–1660 cm1 are
assigned to a-helices and the bands between 1612–1642 cm1 aremparison of the second derivative FTIR spectrum in the amide I region
econdary structures. (C) Comparison between the CD spectra of NLf and
This journal is ª The Royal Society of Chemistry 2010
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View Onlineattributed to b-sheets. Similarly the bands between 1662–
1688 cm1 are assigned to b-turns and the band at 1648 
2 cm1 indicates the presence of random coil structures.42,45,47
Hence, in the second derivative FTIR spectrum of NLf, the
intensity of the bands at 1651 and 1657 cm1 were assigned to
a helices. For b-sheets the bands assigned are from 1615–
1639 cm1. A new band appearing at 1648 cm1 in the case of
AuQC@NLf is assigned to random coil and unordered structures
and the bands between 1664–1685 cm1 are assigned to b-turns.
By comparing NLf and AuQC@NLf spectra, it can be seen that
after the formation of the clusters, there is substantial change in
the conformation of the protein as there is decrease in intensity of
a-helical and b-sheet structures in the 1600–1655 cm1 region.
Thus a large change in the protein structure is evident.
Fig. 5C shows a comparison of the Far-UV CD spectra of NLf
and AuQC@NLf. In the case of NLf, two negative bands at
208 nm and 222 nm indicate the presence of a-helix in the protein
secondary structure. However, the valley at 222 nm is shallower
than usually found for other proteins containing a helical
structures.45,46 This may be interpreted as the presence of b-sheets
and random coil structures in this conformational state.
However, after the formation of clusters, the CD spectrum shows
that the negative band at 208 nm present in NLf CD spectrum is
shifted to 202 nm in the case of AuQC@NLf. This implies
a decrease in a-helical content and increase in b-sheet and
random coil structures47 which corroborates with the FTIR
result.3.6 pH and metal ion sensitivity
The as-synthesized AuQC@NLf was tested for its sensitivity
towards metal ions such as Cu2+, Ag+, Ca2+, Ni2+, Co3+, Fe3+ and
Zn2+. Chlorides and nitrates of the metals were used. Final
concentration of the metal ions in the 1000 ppm cluster solution
was 10 ppm. After 10 min, photoluminescence spectra were taken
to study the sensitivity of the cluster towards metal ions.
Maximum quenching of luminescence intensity was observed for
cupric ions and in the case of silver ions luminescence intensity
was increased about two fold. The reason of AuQC@NLf
quenching by Cu2+ at 10 ppm was found to be aggregation
manifested as a decrease in absorbance in UV-Vis (Fig. S9 of the
ESI†). However, ferric ions had very little effect on luminescence
intensity since its concentration was very low in this caseFig. 6 (A) Bar diagram showing changes in the luminescence intensity of
clusters in presence of different metal ions and (B) corresponding
photograph of the solutions in UV light. (C) Bar diagram showing the
changes in luminescence intensity of clusters at various pH and (D)
corresponding photograph of the solutions in UV light.
This journal is ª The Royal Society of Chemistry 2010(Fig. 6A). This change can be observed visually too as shown in
Fig. 6B. Studies with various Cu2+ salts showed that the anion
dependence of luminescence was minimal.
The sample was tested for its stability as a function of pH.
Deionised water was used for preparing the cluster solution and
pH was adjusted to the desired value using NaOH and HCl by
keeping the cluster concentration constant. As the cluster is
encapsulated in a protein, the effect of pH on the capping must
be prominent compared to its effect on the Au core. Hence while
studying effect of pH on AuQC@NLf emission, samples at
different pH were excited at 370 nm and emission intensity of
clusters at 650 nm was studied. Fig. 6C shows the variation in
intensity of emission at various pH. As the pH of the solution
was changed to alkaline, a red shift was observed in the emission
peak. The data are presented in the supplementary information
(Fig. S8 of the ESI†). The clusters show maximum intensity near
neutral pH, but the luminescence is observable even to the naked
eye throughout the entire window investigated, although it
decreases significantly at extremes of acidity and alkalinity.4. Conclusions
Luminescent gold clusters have been synthesized using a thera-
peutically important protein, lactoferrin. The iron binding milk
protein-based synthesis may be considered as green. Two distinct
cluster cores have been identified by mass spectrometry and sub-
nanometre cores were observed in TEM. Both Au nanoparticles
and luminescent clusters are prepared by the same protein, by
varying the concentrations. Cluster formation was observed in
all the three forms of the protein, NLf, ALf and HLf. Products
were characterized by UV-visible, photoluminescence, XPS, FT-
IR and CD spectroscopies and mass spectrometry. FRET
occurring between protein and cluster was characterized. The
cluster showed metal ion sensitivity; maximum quenching was
observed with cupric ions and not with ferric ions. Clusters were
found to be stable over the entire pH range of 1–14 and a red shift
was observed in the emission peak in extreme alkaline pH. As the
protein is known for its diverse properties and applications, we
expect this new system of gold quantum clusters in lactoferrin to
be useful in drug delivery, imaging and diagnostics. Further
studies will be required to get precise details about location of the
cluster inside the protein. These luminescent clusters inside the
protein have opened up new area at the nano–bio interface. The
present study opens up many questions such as how the func-
tionality of the protein changes upon cluster formation, whether
the protein’s cryptic epitopes are exposed and in turn, does it
become immunogenic, whether iron binding sites remain func-
tional or impaired by cluster formation and what is the nature of
cluster formation in other forms of the protein. Detailed studies
are required to answer these.Acknowledgements
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